AstraZeneca Pharma has declared its second quarter results. The company's Q2 net profit was up at Rs 17.5 crore versus Rs 13 crore.
Its net sales were up at Rs 124 crore versus Rs 97.4 crore.
The company's trailing 12-month (TTM) EPS was at Rs 17.99 per share. (Jun, 2010). The stock's price-to-earnings (P/E) ratio was 62.92. The latest book value of the company is Rs 57.81 per share.
At current value, the price-to-book value of the company was 19.58. The dividend yield of the company was 1.33%.